Evidence map›Paper›PMID 21857655›Full record

ArticleNature immunology2011

The opposing roles of the transcription factor E2A and its antagonist Id3 that orchestrate and enforce the naive fate of T cells.

Masaki Miyazaki, Richard R Rivera, Kazuko Miyazaki, Yin C Lin, Yasutoshi Agata, Cornelis Murre

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 138 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Atomistic TCR-ligand interactions instruct memory T-cell differentiation.bioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. HEB Restrains Effector Gene Expression during Early CD8Molecular and cellular biology · 2025
    Article
  10. Article
  11. Transcriptional network dynamics in early T cell development.The Journal of experimental medicine · 2024
    Review
  12. The CD8Immunity · 2024
    Article
  13. The Function of E2A in B-Cell Development.Advances in experimental medicine and biology · 2024
    Review
  14. Article
  15. Review
  16. Transcriptional programming of CD4Science immunology · 2023
    Article
  17. Review
  18. Review
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Masaki MiyazakiDepartment of Molecular Biology, University of California, San Diego, La Jolla, California, USA.
Richard R Rivera
Kazuko Miyazaki
Yin C Lin
Yasutoshi Agata
Cornelis Murre
University of California, San Diego · USKyoto University · JP

Funding

E2A as a Tumor SuppressorR01CA078384 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MURRE, CORNELIS · 1999 to 2013
$5.4M
E PROTEIN AND B CELL DIFFERENTIATIONR37CA054198 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MURRE, CORNELIS · 2001 to 2008
$3.5M
NCI NIH HHS R01 CA078384NCI NIH HHS R37 CA054198
6 · The paper itself

Abstract

It is established that the transcription factor E2A and its antagonist Id3 modulate the checkpoints consisting of the precursor to the T cell antigen receptor (pre-TCR) and the TCR. Here we demonstrate that Id3 expression was higher beyond the pre-TCR checkpoint, remained high in naive T cells and showed a bimodal pattern in the effector-memory population. We show how E2A promoted T lineage specification and how pre-TCR-mediated signaling affected E2A genome-wide occupancy. Thymi in Id3-deficient mice had aberrant development of effector-memory cells, higher expression of the chemokine receptor CXCR5 and the transcriptional repressor Bcl-6 and, unexpectedly, T cell-B cell conjugates and B cell follicles. Collectively, our data show how E2A acted globally to orchestrate development into the T lineage and that Id3 antagonized E2A activity beyond the pre-TCR checkpoint to enforce the naive fate of T cells.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsImmunologic MemoryImmunophenotypingInhibitor of Differentiation ProteinsLeukocyte Common AntigensMiceMice, Inbred C57BLReceptors, Antigen, T-CellReceptors, CXCR5SpleenThymus GlandT-LymphocytesBasic Helix-Loop-Helix ProteinsCXCR5 protein, mouseIdb3 protein, mouseInhibitor of Differentiation ProteinsLeukocyte Common AntigensReceptors, Antigen, T-CellReceptors, CXCR5Tcf3 protein, mouse

Identifiers

PMID21857655
PMCPMC3178719
OpenAlexW1971329821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.